NCT00475514View on ClinicalTrials.gov

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Migraine
Interventions
DRUG

Frovatriptan 2.5mg QD

DRUG

Frovatriptan 2.5 mg BID

DRUG

placebo

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY